Immunotherapy of aspergillosis

Clinical Microbiology and Infection

Volumn 18, Issue 2, 2012, Pages 120-125

  Carvalho, A ^a,b,c   Cunha, C ^a   Bistoni, F ^a   Romani, L ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Aspergillosis; Immunotherapy; Single nucleotide polymorphism

Indexed keywords

ANTIINFLAMMATORY AGENT; COLONY STIMULATING FACTOR; FUNGUS VACCINE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; PENTRAXIN 3; RECOMBINANT GAMMA INTERFERON; SMALL INTERFERING RNA;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ASPERGILLOSIS; CELL THERAPY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; FUNGAL SPORE GERMINATION; GRANULOCYTE TRANSFUSION; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFLAMMATORY DISEASE; INNATE IMMUNITY; OPPORTUNISTIC INFECTION; PERSONALIZED MEDICINE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNA INTERFERENCE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 84856138864     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03681.x     Document Type: Review

References (33)

1. Romani L. Dendritic cells in Aspergillus infection and allergy. In: Latce JP and Steinbach WJ, eds. Aspergillus fumigatus and aspergillosis. Washington DC: ASM Press, 2009.
2. Cunha C, Romani L, Carvalho A. Cracking the Toll-like receptor code in fungal infections. Expert Rev Anti Infect Ther 2010; 8: 1121-1137.
3. Mezger M, Einsele H, Loeffler J. Genetic susceptibility to infections with Aspergillus fumigatus. Crit Rev Microbiol 2010; 36: 168-177.
4. Aimanianda V, Bayry J, Bozza S et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009; 460: 1117-1121.
5. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11: 275-288.
6. Torosantucci A, Bromuro C, Chiani P et al. A novel glycoconjugate vaccine against fungal pathogens. J Exp Med 2005; 202: 597-606.
7. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7: 395-401.
8. Holland SM, DeLeo FR, Elloumi HZ et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357: 1608-1619.
9. Sorci G, Giovannini G, Riuzzi F et al. The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathog 2011; 7: e1001315.
10. Romani L, Fallarino F, De Luca A et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451: 211-215.
11. Roilides E, Lamaignere CG, Farmaki E. Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy. Int J Infect Dis 2002; 6: 154-163.
12. Safdar A. Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections. Bone Marrow Transplant 2006; 38: 327-337.
13. Segal BH, Kwon-Chung J, Walsh TJ et al. Immunotherapy for fungal infections. Clin Infect Dis 2006; 42: 507-515.
14. Stull DM. Colony-stimulating factors: beyond the effects on hematopoiesis. Am J Health Syst Pharm 2002; 59: S12-S20.
15. Codarri L, Gyulveszi G, Tosevski V et al. Rorgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011; 12: 560-567.
16. Massey E, Paulus U, Doree C, Stanworth S. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 2009; 1: CD005341.
17. Price TH. Granulocyte transfusion: current status. Semin Hematol 2007; 44: 15-23.
18. Tramsen L, Schmidt S, Roeger F, Koehl U, Lehrnbecher T. Challenges and prospects of adoptive immunotherapy in prevention and treatment of opportunistic mycoses in hematologic transplant recipients. Curr Infect Dis Rep 2010; 12: 444-449.
19. Stuehler C, Khanna N, Bozza S et al. Cross-protective Th1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011; 117: 5881-5891.
20. Di Ianni M, Falzetti F, Carotti A et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117: 3921-3928.
21. Garlanda C, Hirsch E, Bozza S et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420: 182-186.
22. D'Angelo C, De Luca A, Zelante T et al. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. J Immunol 2009; 183: 4609-4618.
23. Chiarini M, Sabelli C, Melotti P et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun 2010; 11: 665-670.
24. Romani L, Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol 2006; 14: 183-189.
25. Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2695-2706.
26. Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 2009; 9: 593-608.
27. Pierluigi B, D'Angelo C, Fallarino F et al. Thymosin alpha1: the regulator of regulators? Ann N Y Acad Sci 2010; 1194: 1-5.
28. Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther 2006; 13: 644-670.
29. Bonifazi P, D'Angelo C, Zagarella S et al. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol 2010; 3: 193-205.
30. Cutler JE, Deepe GS Jr, Klein BS. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 2007; 5: 13-28.
31. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008; 197: 618-621.
32. Bochud PY, Chien JW, Marr KA et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008; 359: 1766-1777.
33. Cunha C, Di Ianni M, Bozza S et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 2010; 116: 5394-5402.